News
🇺🇸 FDALatest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 1–12 of 807 articles
Quick answer
NovaPharmaNews United States & Americas news feed tracks 807 published stories — FDA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
Adial Pharmaceuticals Completes Azora Merger, Expands Ulcerative Colitis Pipeline
Biotech’s coming of age: AI, capital efficiency and China reshape the field
Edgewise Therapeutics’ EDG-7500 clears key Phase 2 test
Celiac disease therapies enter a new era of innovation
FDA approves OTC Rextovy, broadening naloxone access for opioid overdose
Neumora navacaprant fails Phase 3 as EnGene cuts 50% of staff
Global hematology trials keep research patient-centered and regionally relevant
Lilly’s early JAK data raises myelofibrosis competition question
FDA authorizes emergency pet treatment for New World screwworm
FDA guidance on sharing potential NDA patent information: what changes now
Hillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
FDA expands Tzield to certain pediatric patients with recent Stage 3 T1D
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.